Brett Hauber

ORCID: 0000-0003-3129-7268 · 4 papers in corpus
observational 2025
Attribute preferences associated with gonadotropin-releasing hormone agonists/antagonists among women with endometriosis in the United States
Women's health (London, England) ·doi:10.1177/17455057251331700

BACKGROUND: Endometriosis symptoms have multifaceted manifestations, and there are few approved nonsurgical treatment options. Gonadotropin-releasing hormone (GnRH) agonists/antagonists for endometriosis vary on efficacy, safety profile, an…

other 2025
Social media to understand the endometriosis patient journey: Listening to influences driving treatment choices
Women's health (London, England) ·doi:10.1177/17455057241311765

BACKGROUND: Previous research has identified treatment attributes and outcomes for endometriosis patients, highlighting the need for tailored interventions to improve patient care. These studies emphasize the need to understand patient expe…

observational 2025
Understanding Preferences, Needs, and Expectations for Pharmaceutical Treatment of Symptomatic Uterine Fibroids Based on Surveys of Healthcare Providers and Patients
International journal of women's health ·doi:10.2147/ijwh.s523846

BACKGROUND: Limited evidence is available regarding preferences of women with uterine fibroids (UF) and treating healthcare providers (HCPs) regarding treatment attributes; this evidence could contribute to patient-centered shared decision-…

2022
PCR291 Preferences for Key Features of Gonadotropin-Releasing Hormone Analogues Among Women With Endometriosis in the United States
·doi:10.1016/j.jval.2022.09.2224